do all patients require maintenance therapy following allosct?
Published 2 months ago • 137 plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
1:02
maintenance therapy following treatment for amyloidosis
-
5:00
phase i study of ven/aza maintenance therapy following ven/flubu2 ric allosct in high-risk mds/aml
-
0:58
management strategies for acute and chronic gvhd following allosct
-
21:09
29 chapter 06 part 05 pathogens and oncology
-
9:44
an update on the quantum-first trial: quizartinib plus chemotherapy in flt3-mutated aml
-
3:49
zuma-3: impact of prior blinatumomab and allosct
-
3:34
maintenance therapy following salvage asct for multiple myeloma
-
2:52
the evolving role of maintenance therapy post-asct in mm
-
5:05
determining the most suitable consolidation therapies for aml by defining patient risk group
-
2:26
lenalidomide as post-autosct maintenance therapy for multiple myeloma
-
1:44
improving maintenance therapy in aml: exploring the role of idh inhibitors
-
4:28
approaching patients with mds and aml who relapse after allosct & strategies to prevent relapse
-
5:01
treatment options for high-risk aml
-
4:15
using mrd to guide post-allosct treatment decisions in aml
-
2:21
post-transplant maintenance strategies in aml
-
0:48
an overview of challenges that remain in the treatment of patients with al amyloidosis
-
1:40
outcomes & treatment options for patients with aml who relapse after allohsct
-
3:09
treatment strategies for chl patients after auto-hsct
-
1:58
should we transplant or not in frontline therapy for mcl?
-
1:03
what is induction therapy for autologous stem cell transplanation?
-
2:47
management of relapse following allohsct in patients with aml and mds